vTv Therapeutics (VTVT) Non-Current Assets (2014 - 2026)

vTv Therapeutics (VTVT) has 13 years of Non-Current Assets data on file, last reported at $5000.0 in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 95.5% year-over-year to $5000.0; the trailing twelve-month figure through Mar 2026 stood at $123000.0 (down 83.1% YoY), and the FY2025 full-year result was $6000.0, down 96.08% from the prior year.
• Non-Current Assets eased to $5000.0 in Q1 2026, from $6000.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $8.5 million in Q2 2023 to a low of $5000.0 in Q1 2026.
• A 5-year average of $2.9 million and a median of $311000.0 in 2024 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets jumped 33.04% in 2023 and slumped 96.96% in 2024, its largest moves.
• Tracing VTVT's Non-Current Assets over 5 years: stood at $6.1 million in 2022, then sank by 94.12% to $361000.0 in 2023, then sank by 57.62% to $153000.0 in 2024, then plunged by 96.08% to $6000.0 in 2025, then slipped by 16.67% to $5000.0 in 2026.
• Business Quant data shows VTVT's Non-Current Assets at $5000.0 in Q1 2026, $6000.0 in Q4 2025, and $38000.0 in Q3 2025.